![Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2020/02/New-Project-20-1-1-550x325.jpg)
Equilibre Attitude (EA Pharma) strengthens its expertise in Oligotherapy with the acquisition of Labcatal, its third build-up under Motion ownership - Motion Equity Partners
![RYSH Aquarium Dosing Pump DC12V/24V Peristaltic Pump Water Pump Laboratory Dosing Pump for Aquariums (Black, 24V 1 x 3) : Amazon.com.be: Industrial & Scientific RYSH Aquarium Dosing Pump DC12V/24V Peristaltic Pump Water Pump Laboratory Dosing Pump for Aquariums (Black, 24V 1 x 3) : Amazon.com.be: Industrial & Scientific](https://m.media-amazon.com/images/I/41EAAZUnPHL._SR600%2C315_PIWhiteStrip%2CBottomLeft%2C0%2C35_SCLZZZZZZZ_FMpng_BG255%2C255%2C255.jpg)
RYSH Aquarium Dosing Pump DC12V/24V Peristaltic Pump Water Pump Laboratory Dosing Pump for Aquariums (Black, 24V 1 x 3) : Amazon.com.be: Industrial & Scientific
![EA Pharma strengthens its international presence with the acquisition of the Spanish Group DRASANVI, its fourth build-up with Motion - Motion Equity Partners EA Pharma strengthens its international presence with the acquisition of the Spanish Group DRASANVI, its fourth build-up with Motion - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2021/08/New-Project-1.jpg)
EA Pharma strengthens its international presence with the acquisition of the Spanish Group DRASANVI, its fourth build-up with Motion - Motion Equity Partners
![Les fonds conseillés par Motion Equity Partners annoncent la signature de l'acquisition du Laboratoire Equilibre Attitude - Motion Equity Partners Les fonds conseillés par Motion Equity Partners annoncent la signature de l'acquisition du Laboratoire Equilibre Attitude - Motion Equity Partners](https://www.motionequitypartners.com/wp-content/uploads/2018/12/EA-Pharma-brands-vf.png)
Les fonds conseillés par Motion Equity Partners annoncent la signature de l'acquisition du Laboratoire Equilibre Attitude - Motion Equity Partners
![EQT AB publiera son rapport de fin d'année 2022 et organisera une conférence téléphonique le 18 janvier | EuropaWire.eu | The European Union's press release distribution & newswire service EQT AB publiera son rapport de fin d'année 2022 et organisera une conférence téléphonique le 18 janvier | EuropaWire.eu | The European Union's press release distribution & newswire service](https://news.europawire.eu/wp-content/uploads/2023/01/EQT-logo.jpg)